For the Inventor, By the Inventor

Enter assignee name

Ballerup, Denmark

Nsgene A/s

USPTO Granted Patents = 19

CIPO Patents = 2

EPO Patents = 9

Forward Citations = 111

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Teit E Johansen (11 out of 16 patents)

Lars Ulrik Wahlberg (7 out of 16 patents)

Anthony Rossomando (4 out of 15 patents)

4. Lars U Wahlberg (4 out of 7 patents)

5. Dinah W Y Sah (4 out of 8 patents)

6. Philip Kusk (3 out of 7 patents)

7. Jesper Roland Jørgensen (3 out of 4 patents)

8. Nikolaj Blom (2 out of 3 patents)

9. Kenneth Campbell (2 out of 4 patents)

10. Cecilia Eriksson (2 out of 4 patents)

11. Charlotta Skogh (2 out of 4 patents)

12. Klas Wictorin (2 out of 4 patents)

13. Claus Hansen (2 out of 2 patents)

14. Jesper Roland Jorgensen (2 out of 5 patents)

15. Jens Tornøe (1 out of 3 patents)

19 patents: Sort by Forward Citations

1. 9474786 - Treatment of allodynia (2016-10-25),

2. 9364427 - Implantable therapy system for treating a living being with an active factor (2016-06-14),

3. 9314502 - Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain (2016-04-19),

4. 9121037 - Cell lines and their use in encapsulated cell biodelivery (2015-09-01),

5. 9068015 - Therapeutic use of a growth factor, METRNL (2015-06-30),

6. 8815810 - Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain (2014-08-26),

7. 8741340 - Cell lines and their use in encapsulated cell biodelivery (2014-06-03),

8. 8404642 - Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain (2013-03-26),

9. 8217146 - Neurotrophic factors and methods of use thereof (2012-07-10),

10. 8088567 - Human immortalised neural precursor cell line (2012-01-03),

11. 7655463 - Methods of activating RET receptor tyrosine kinase using neurotrophic factors (2010-02-02),

12. 7651853 - [object Object] (2010-01-26),

13. 7601518 - Secretion of neublastin (2009-10-13),

14. 7358228 - Methods of treating pain using neurotrophic factors (2008-04-15),

15. 7303912 - Cultures of GFAP nestin cells that differentiate to neurons (2007-12-04),

NsGene A/S is a biotechnology company based in Denmark. They specialize in the development and production of innovative gene therapies for various diseases. With a focus on neuroscience, NsGene aims to provide groundbreaking solutions to improve patients' quality of life. By combining cutting-edge research with advanced technologies, they strive to make significant contributions to the field of gene therapy and bring about transformative treatments. Visit their website for more information on their latest developments and offerings.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#15 in Ballerup

#149 in Denmark

#31,713 in the World

Ballerup, Denmark

Nsgene A/s

Forward Citations = 111

21 inventors:

Teit E Johansen (11 out of 16 patents)

Lars Ulrik Wahlberg (7 out of 16 patents)

Anthony Rossomando (4 out of 15 patents)

4. Lars U Wahlberg (4 out of 7 patents)

5. Dinah W Y Sah (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…